<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><label>Table 1.</label><caption><title>Parameter values estimated in currently available studies, along with accompanying uncertainties and assumptions.</title><p>Ranges in the final column reflect confidence interval, credible interval, standard error or range reported by each study referenced.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Parameter</th><th valign="top">Best estimate <break/>(Used in <xref ref-type="fig" rid="fig2">Figure 2</xref>)</th><th valign="top">Plausible range <break/>(Used in <xref ref-type="fig" rid="fig3">Figure 3</xref>)</th><th valign="top">References <break/>and notes</th></tr></thead><tbody><tr><td valign="top">Mean incubation period</td><td valign="top">5.5 days <break/>Sensitivity: 4.5 or 6.5 days</td><td valign="top">4.5&#8211;6.5 days</td><td rowspan="2" valign="top">3&#8211;6 days, n&#160;=&#160;4&#160;(<xref ref-type="bibr" rid="bib8">Chan et al., 2020</xref>)* <break/>5.2 (4.1&#8211;7.0) days, n&#160;&lt;&#160;425&#160;(<xref ref-type="bibr" rid="bib29">Li et al., 2020</xref>)<sup>&#8224;</sup> <break/>5.2 (4.4&#8211;6.0) days, n&#160;=&#160;101&#160;(<xref ref-type="bibr" rid="bib28">Lauer et al., 2020</xref>)<sup>&#8224;</sup> <break/>6.5 (5.6&#8211;7.9) days, n&#160;=&#160;88&#160;(<xref ref-type="bibr" rid="bib1">Backer et al., 2020</xref>)<sup>&#8224;</sup></td></tr><tr><td valign="top">Incubation period distribution</td><td colspan="2" valign="top">Gamma distribution with mean as above, and standard deviation&#160;=&#160;2.25</td></tr><tr><td valign="top">Percent of cases subclinical <break/>(No fever or cough)</td><td colspan="2" valign="top">Best case scenario: 5% <break/>Middle case scenario: 25% <break/>Worst case scenario: 50%</td><td valign="top"><bold>Clinical data:</bold> <break/>83% fever, 67% cough, n&#160;=&#160;6&#160;(<xref ref-type="bibr" rid="bib8">Chan et al., 2020</xref>) <break/>83% fever, 82% cough, n&#160;=&#160;99&#160;(<xref ref-type="bibr" rid="bib10">Chen et al., 2020</xref>) <break/>98% fever, 76% cough, n&#160;=&#160;41&#160;(<xref ref-type="bibr" rid="bib22">Huang et al., 2020</xref>) <break/>43.8% fever at hospital admission, <break/>88.7% fever during hospitalization, n =&#160;1099&#160;(<xref ref-type="bibr" rid="bib18">Guan et al., 2020</xref>) <break/><bold>Active monitoring after repatriation flights or on cruise ships: % asymptomatic at diagnosis</bold> <break/>31.2% (111/355)&#160;(<xref ref-type="bibr" rid="bib25">Japan Ministry of Health, Labor and Welfare, 2020</xref>) <break/>65.2% (5 of 8)&#160;(<xref ref-type="bibr" rid="bib38">Nishiura et al., 2020</xref>) <break/>70.0% (7 of 10)&#160;(<xref ref-type="bibr" rid="bib14">Dorigatti et al., 2020</xref>)</td></tr><tr><td valign="top">R<sub>0</sub></td><td valign="top">No effect in individual-level analysis.</td><td valign="top">1.5&#8211;4.0</td><td valign="top">2.2 (1.4&#8211;3.8)&#160;(<xref ref-type="bibr" rid="bib42">Riou and Althaus, 2020</xref>) <break/>2.2 (1.4&#8211;3.9) (<xref ref-type="bibr" rid="bib29">Li et al., 2020</xref>) <break/>2.6 (1.5&#8211;3.5) (<xref ref-type="bibr" rid="bib23">Imai et al., 2020</xref>) <break/>2.7 (2.5&#8211;2.9) (<xref ref-type="bibr" rid="bib56">Wu et al., 2020</xref>) <break/>4.5&#160;(4.4-4.6) (<xref ref-type="bibr" rid="bib30">Liu et al., 2020</xref>) <break/>3.8&#160;(3.6-4.0) (<xref ref-type="bibr" rid="bib41">Read et al., 2020</xref>) <break/>4.08 (3.37&#8211;4.77) (<xref ref-type="bibr" rid="bib6">Cao et al., 2020</xref>) <break/>4.7 (2.8&#8211;7.6) (<xref ref-type="bibr" rid="bib43">Sanche et al., 2020</xref>) <break/>6.3&#160;(3.3-11.3)&#160;(<xref ref-type="bibr" rid="bib43">Sanche et al., 2020</xref>) <break/>6.47 (5.71&#8211;7.23) (<xref ref-type="bibr" rid="bib49">Tang et al., 2020</xref>)</td></tr><tr><td valign="top">Percent of travellers aware of exposure risk</td><td valign="top">20%</td><td valign="top">5&#8211;40%</td><td valign="top">We assume a low percentage, as no specific risk factors have been identified, and known times or sources of exposure are rarely reported in existing line lists.</td></tr><tr><td valign="top">Sensitivity of infrared thermal scanners for fever</td><td valign="top">70%</td><td valign="top">60&#8211;90%</td><td valign="top">Most studies estimated sensitivity between 60&#8211;88% (<xref ref-type="bibr" rid="bib5">Bitar et al., 2009</xref>; <xref ref-type="bibr" rid="bib39">Priest et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Tay et al., 2015</xref>). But a handful of studies estimated very low sensitivity (4&#8211;30%). In general, sensitivity depended on the device used, body area targeted and ambient temperature.</td></tr><tr><td valign="top">Probability that travellers self-report exposure risk</td><td valign="top">25%</td><td valign="top">5&#8211;25%</td><td valign="top">25% is an upper-bound estimate based on outcomes of past screening initiatives. <break/>(<xref ref-type="bibr" rid="bib16">Gostic et al., 2015</xref>)</td></tr><tr><td valign="top">Time from symptom onset to patient isolation <break/>(After which we assume travel is not possible)</td><td valign="top">No effect in individual-level analysis.</td><td valign="top">3&#8211;7 days</td><td valign="top">Median 7 days from onset to hospitalization (n&#160;=&#160;6) (<xref ref-type="bibr" rid="bib8">Chan et al., 2020</xref>) <break/>Mean 2.9 days onset to patient isolation (n&#160;=&#160;164) (<xref ref-type="bibr" rid="bib30">Liu et al., 2020</xref>) <break/>Median 7 days from onset to hospitalization (n&#160;=&#160;41) (<xref ref-type="bibr" rid="bib22">Huang et al., 2020</xref>) <break/>As awareness increases, times to isolation may decline.</td></tr></tbody></table><table-wrap-foot><fn><p>* From family cluster.</p><p>&#8224; Parametric distributions fit to cases with known dates of exposure or travel to and from Wuhan.</p></fn></table-wrap-foot></table-wrap>